Sign In

Login

Password

Forgot Password ? Sign Up

مراقبة ما بعد التسويق (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "مراقبة ما بعد التسويق" in Arabic language version.

refsWebsite
Global rank Arabic rank
8web.archive.org
1st place
1st place
4fda.gov
447th place
393rd place
3doi.org
2nd place
5th place
2archive.today
14th place
41st place
2adisonline.com
low place
low place
1clin-r.com
low place
low place
1hc-sc.gc.ca
low place
4,231st place
1europa.eu
68th place
91st place
1worldcat.org
5th place
4th place
1citemedical.com
low place
low place

adisonline.com

  • "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. ج. 24 ع. 5: 281–288. 2010. DOI:10.1007/bf03256826. مؤرشف من الأصل في 2012-07-07. اطلع عليه بتاريخ 2011-06-17.
  • "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. ج. 24 ع. 5: 281–288. 2010. DOI:10.1007/bf03256826. مؤرشف من الأصل في 2012-07-07. اطلع عليه بتاريخ 2011-06-17.McNeil JJ, Piccenna L, Ronaldson K, et al. (2010). "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. 24 (5): 281–288. doi:10.1007/bf03256826. Archived from the original نسخة محفوظة 7 يوليو 2012 at Archive.is on 2012-07-07. Retrieved 2011-06-17.

archive.today

  • "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. ج. 24 ع. 5: 281–288. 2010. DOI:10.1007/bf03256826. مؤرشف من الأصل في 2012-07-07. اطلع عليه بتاريخ 2011-06-17.
  • "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. ج. 24 ع. 5: 281–288. 2010. DOI:10.1007/bf03256826. مؤرشف من الأصل في 2012-07-07. اطلع عليه بتاريخ 2011-06-17.McNeil JJ, Piccenna L, Ronaldson K, et al. (2010). "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. 24 (5): 281–288. doi:10.1007/bf03256826. Archived from the original نسخة محفوظة 7 يوليو 2012 at Archive.is on 2012-07-07. Retrieved 2011-06-17.

citemedical.com

clin-r.com

doi.org

  • "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. ج. 24 ع. 5: 281–288. 2010. DOI:10.1007/bf03256826. مؤرشف من الأصل في 2012-07-07. اطلع عليه بتاريخ 2011-06-17.
  • "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. ج. 24 ع. 5: 281–288. 2010. DOI:10.1007/bf03256826. مؤرشف من الأصل في 2012-07-07. اطلع عليه بتاريخ 2011-06-17.McNeil JJ, Piccenna L, Ronaldson K, et al. (2010). "The Value of Patient-Centred Registries in Phase IV Drug Surveillance". Pharm Med. 24 (5): 281–288. doi:10.1007/bf03256826. Archived from the original نسخة محفوظة 7 يوليو 2012 at Archive.is on 2012-07-07. Retrieved 2011-06-17.
  • Zippel، Claus؛ Bohnet-Joschko، Sabine (2017). "Post market surveillance in the german medical device sector - current state and future perspectives". Health Policy (Amsterdam, Netherlands). ج. 121 ع. 8: 880–886. DOI:10.1016/j.healthpol.2017.06.005. ISSN:1872-6054.

europa.eu

eur-lex.europa.eu

fda.gov

fda.gov

accessdata.fda.gov

hc-sc.gc.ca

web.archive.org

worldcat.org

  • Zippel، Claus؛ Bohnet-Joschko، Sabine (2017). "Post market surveillance in the german medical device sector - current state and future perspectives". Health Policy (Amsterdam, Netherlands). ج. 121 ع. 8: 880–886. DOI:10.1016/j.healthpol.2017.06.005. ISSN:1872-6054.